Sales & Marketing From graduate to chairman: My 30 years in pharma In today’s world, working at the same company for 30 years is increasingly rare. Yet, that’s exactly what I’ve done.
News FDA won't approve Summit, Akeso's ivonescimab The FDA has said it cannot approve Summit /Akeso's ivonescimab, delaying a drug that could usher in a new era of dual-acting cancer immunotherapies.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.
